STOCK TITAN

Director at Vital Farms (VITL) buys 2,500 shares of stock

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

Vital Farms director Kelly J. Kennedy bought 2,500 shares of common stock in an open-market transaction at a weighted average price of $8.40 per share. After this purchase, Kennedy directly owns 22,927 Vital Farms shares. The trade was executed in multiple transactions priced between $8.28 and $8.40.

Positive

  • None.

Negative

  • None.
Insider Kennedy Kelly J.
Role null
Bought 2,500 shs ($21K)
Type Security Shares Price Value
Purchase Common Stock 2,500 $8.40 $21K
Holdings After Transaction: Common Stock — 22,927 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares purchased 2,500 shares Open-market purchase on May 14, 2026
Weighted average price $8.40 per share Price for the 2,500-share purchase
Post-transaction holdings 22,927 shares Direct ownership after the transaction
Trade price range $8.28–$8.40 Range of individual trade prices for the transaction
open-market purchase financial
"bought 2,500 shares of common stock in an open-market transaction"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
weighted average price financial
"at a weighted average price of $8.40 per share"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Form 4 regulatory
"What insider transaction did Vital Farms (VITL) disclose in this Form 4?"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
transaction code regulatory
"Form 4 coding shows a “P” transaction code and classifies the activity as a buy"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kennedy Kelly J.

(Last)(First)(Middle)
C/O VITAL FARMS, INC.
3601 SOUTH CONGRESS AVENUE, SUITE A100

(Street)
AUSTIN TEXAS 78704

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Vital Farms, Inc. [ VITL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/14/2026P2,500A$8.4(1)22,927D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.28 to $8.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ Francis Cullo, Attorney-in-Fact05/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Vital Farms (VITL) disclose in this Form 4?

Vital Farms disclosed that director Kelly J. Kennedy bought 2,500 shares of common stock in an open-market transaction. The weighted average purchase price was $8.40 per share, and the trade occurred on May 14, 2026.

At what prices did Kelly J. Kennedy trade Vital Farms (VITL) shares?

Kelly J. Kennedy’s trade used a weighted average price of $8.40 per share. The shares were transacted in multiple executions, with individual prices ranging between $8.28 and $8.40 inclusive, according to the Form 4 footnote.

How many Vital Farms (VITL) shares does Kelly J. Kennedy own after this trade?

After the reported transaction, Kelly J. Kennedy directly owns 22,927 shares of Vital Farms common stock. This post-transaction holding reflects the addition of 2,500 shares purchased in the May 14, 2026 open-market transaction.

What does the Form 4 say about the pricing of Kelly J. Kennedy’s VITL trade?

The Form 4 states that the reported $8.40 price is a weighted average. The 2,500 Vital Farms shares were traded in multiple transactions at prices ranging from $8.28 to $8.40 inclusive, with detailed breakdowns available upon request.

Was Kelly J. Kennedy’s Vital Farms (VITL) transaction a purchase or a sale?

The transaction is reported as an open-market purchase of 2,500 Vital Farms common shares. Form 4 coding shows a “P” transaction code and classifies the activity as a buy, increasing Kennedy’s direct ownership to 22,927 shares.